Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Applied Machine Learning for CNS Clinical Trial Risk Assessment: An Interpretable Framework with an ALS Case Study
0
Zitationen
1
Autoren
2026
Jahr
Abstract
This technical report presents an applied framework for assessing risk in central nervous system (CNS) clinical trials, emphasizing interpretable, structured decision-making using biological, clinical, and operational signals. The platform integrates curated trial metadata, biomarker information, and machine learning to flag potential trial risks before execution. A focused amyotrophic lateral sclerosis (ALS) case study illustrates how trial design decisions such as biomarker use, patient stratification, and endpoint selection are translated into explicit risk factors. The report includes baseline scoring, preliminary machine learning evaluation, decision scenarios, and responsible use considerations.
Ähnliche Arbeiten
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
1993 · 7.000 Zit.
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
2006 · 6.489 Zit.
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
2000 · 5.319 Zit.
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
2011 · 5.141 Zit.
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
2011 · 4.913 Zit.